Michael D Pierschbacher - JoVE Visualize

Showing results (1-10 of 6) with videos related to

Pageof 1

Sort By:

Bioorganic & Medicinal Chemistry|August 2, 2002

Incorporation of (2S,3S) and (2S,3R) beta-methyl aspartic acid into RGD-containing peptidesSilke Schabbert, Michael D Pierschbacher, Ralph Heiko Mattern, et al.

Biopolymers|March 3, 2004

Incorporation of thioether building blocks into an alphavbeta3-specific RGD peptide: synthesis and biological activityAudrey Kelleman, Ralph-Heiko Mattern, Michael D Pierschbacher, et al.

Journal of the American Chemical Society|March 21, 2002

Receptor-bound conformation of an alpha(5)beta(1) integrin antagonist by (15)N-edited 2D transferred nuclear overhauser effectsLi Zhang, Ralph-Heiko Mattern, Timothy I Malaney, et al.

Journal of Neurotrauma|October 3, 2013

The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injuryGregory R Hook, Jin Yu, Nancy Sipes, et al.

Cancer Therapy|February 10, 2006

Glioma cell integrin expression and their interactions with integrin antagonists: Research ArticleRalph-Heiko Mattern, Susana B Read, Michael D Pierschbacher, et al.

Biopolymers|January 23, 2003

Studies of the receptor-bound conformation of alphaIIbbeta3 antagonists by 15N-edited NMR spectroscopyElsa Locardi, Ralph-Heiko Mattern, Timothy I Malaney, et al.

Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:

Pageof 1

Bioorganic & Medicinal Chemistry|August 2, 2002

Incorporation of (2S,3S) and (2S,3R) beta-methyl aspartic acid into RGD-containing peptidesSilke Schabbert, Michael D Pierschbacher, Ralph Heiko Mattern, et al.

Biopolymers|March 3, 2004

Incorporation of thioether building blocks into an alphavbeta3-specific RGD peptide: synthesis and biological activityAudrey Kelleman, Ralph-Heiko Mattern, Michael D Pierschbacher, et al.

Journal of the American Chemical Society|March 21, 2002

Receptor-bound conformation of an alpha(5)beta(1) integrin antagonist by (15)N-edited 2D transferred nuclear overhauser effectsLi Zhang, Ralph-Heiko Mattern, Timothy I Malaney, et al.

Journal of Neurotrauma|October 3, 2013

The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injuryGregory R Hook, Jin Yu, Nancy Sipes, et al.

Cancer Therapy|February 10, 2006

Glioma cell integrin expression and their interactions with integrin antagonists: Research ArticleRalph-Heiko Mattern, Susana B Read, Michael D Pierschbacher, et al.

Biopolymers|January 23, 2003

Studies of the receptor-bound conformation of alphaIIbbeta3 antagonists by 15N-edited NMR spectroscopyElsa Locardi, Ralph-Heiko Mattern, Timothy I Malaney, et al.

Pageof 1